CSF2 and cholangiocarcinoma: Patients with high GM-CSF and GM-CSFRα in CCA tissues tended to have more prolonged overall survival (OS) and longer disease-free (DF) survival times than those with low expressions (Figs. 1B–1C and 1E–1F).